Skip to main content
. 2020 Aug;9(4):440–451. doi: 10.21037/hbsn.2020.04.02

Figure 3.

Figure 3

Proposed clinical pathway for managing patients with NELM based on the authors’ institutional experience. NELM, neuroendocrine liver metastases; PNET, pancreatic neuroendocrine tumor; TAE, transarterial embolization; XRT, radiation therapy; PRRT; peptide receptor radionuclide therapy; SSAs, somatostatin analogs.